ArticlePhysiological reports2026
Non-invasive cardiac power measurements in decompensated heart failure in elderly adults: A prospective proof-of-concept study.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this proof-of-concept study, we evaluated the feasibility of non-invasive estimation of cardiac power metrics-total power, steady power, oscillatory power, and oscillatory power fraction-and compared the prognostic and diagnostic value with established echocardiographic metrics. We prospectively included 29 patients (mean age 76 ± 13 years, 24% women) hospitalized with decompensated heart failure. Left ventricular outflow tract flow waveforms were derived from Doppler echocardiography and synchronized with a continuous arterial pressure waveform from a finger-volume-clamp device (INL382, Finapres Medical Systems B.V., Amsterdam, Netherlands). Total power was computed as the integral of the instantaneous pressure-flow product per second, steady power as mean arterial pressure multiplied by mean flow, and oscillatory power as their difference. All measures were calculated from the same consecutive heartbeats covering three respiratory cycles. The feasibility of obtaining cardiac power metrics was 91%. Total, steady, and oscillatory power predicted short-term all-cause mortality (log rank p < 0.015), whereas left ventricular ejection fraction, global longitudinal strain, and myocardial work indices did not. These findings suggest that cardiac power metrics may be useful in risk stratification and warrant validation in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.